FENRETINIDE'S EFFECT ON RISK OF BREAST CANCER RECURRENCE
APPEARS AGE RELATED The vitamin A analog fenretinide has no significant
effect in preventing a second breast malignancy in women with breast cancer,
although it may possibly benefit premenopausal women, a team of Italian and
American researchers report in the November 3rd issue of the Journal of the
National Cancer Institute. http://oncology.medscape.com/13539.rhtml <a
href="http://oncology.medscape.com/13539.rhtml">Read it
Here</a>